Apixaban NOBEL 2.5 mg
Apixaban NOBEL 2.5 mg is a medicine authorised by Swissmedic under authorisation number 69829. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 February 2026 and the authorisation is limited until 18 February 2031. ATC code B01AF02 places the medicine in the group Antithrombotic agents.
| Authorisation number | 69829 |
|---|---|
| Name | Apixaban NOBEL 2.5 mg |
| Full name | Apixaban NOBEL 2.5 mg, Filmtabletten |
| Authorisation holder | NOBEL Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF02 |
| First authorisation | 19 February 2026 |
| Authorisation validity | 18 February 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Apixaban NOBEL 2.5 mg, Filmtabletten | B | 19 February 2026 |
| 2 | Apixaban NOBEL 5 mg, Filmtabletten | B | 19 February 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 2 | 56 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 3 | 100 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 4 | 168 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 5 | 56 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 6 | 100 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 7 | 168 | Tablette(n) | B01AF02 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Apixaban NOBEL 2.5 mg authorised in Switzerland?
Yes. Apixaban NOBEL 2.5 mg is authorised by Swissmedic under authorisation number 69829, data as of 01 September 2026. The authorisation is limited until 18 February 2031.
Which dispensing category does Apixaban NOBEL 2.5 mg have?
Apixaban NOBEL 2.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Apixaban NOBEL 2.5 mg?
The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.